3.87700 EUR
0.017
0.44%
Last update Dec 15, 8:00 AM CET
Main market
Day range
3.87700
3.87700
Previous close
3.86000
Open
3.87700
Access this stock data via API
Subscribe
Aldeyra Therapeutics Inc.
3.88
0.02
0.44%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 41.1M 29.5M 45.4M 43.2M
Selling general and admin 10.1M 13.3M 14.8M 10.8M
Other operating expenses
Operating income -51.2M -42.8M -60.2M -54.0M
Non operating interest income
Income 5.3M 7.3M 2.3M 178.1K
Expense 1.6M 2.1M 1.6M 1.7M
Other income expense
Pretax income -47.6M -37.5M -59.6M -55.5M
Tax provision 0
Net income -47.6M -37.5M -59.6M -55.5M
Basic EPS -0.9 -0.6 -1.1 -1.1
Diluted EPS -0.9 -0.6 -1.1 -1.1
Basic average shares 50.7M 61.4M 58.4M 54.0M
Diluted average shares 50.7M 61.4M 58.4M 54.0M
EBITDA -45.7M -35.2M -57.7M -53.6M
Net income from continuing op. -47.6M -37.5M -59.6M -55.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 35 minutes

08:24
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).